At least 5,000 measles cases in the U.S. in 2026 priced at 96.6% on Polymarket, down 1.8 points, on $340K traded

Measles contract remains heavily weighted toward yes

Polymarket’s contract on whether the U.S. will record at least 5,000 measles cases in 2026 was priced at 96.6%, down 1.8 percentage points, with $340K traded, according to the supplied market snapshot published Oct 29, 2026, at 6:39 AM ET.

The decline leaves the market-implied probability close to certainty, but the price is not a confirmed case count. The supplied material contains no current measles tally or public-health reporting against which to assess that probability.

Limited evidence for the move

The accompanying news summary identified no significant new platform headline in the preceding 30 minutes. It did not establish a measles-specific catalyst for the price change.

According to predictionbubbles.net, its market data comes from Polymarket and Kalshi and refreshes every 15 minutes. The supplied page explains the distinction between probability changes and total traded volume, but does not independently display the measles contract’s figures or settlement terms.

What it means for prediction markets

• High probability, modest retreat: The 96.6% price still reflects a strong market expectation that the threshold will be reached, despite the 1.8-point decline.
• Volume is not verification: The $340K traded measures activity in the contract, not evidence that the U.S. has recorded at least 5,000 cases.
• Resolution details remain missing: The supplied material does not identify the contract’s case-count source or precise settlement rules, limiting conclusions about how the outcome will be determined.